OVERSEE-I
Identification of Potential Improvements in the Acute Care Pathway for Cancer Patients in the Emergency Department (OVERSEE - I Trial)
Sponsor study identifier
observational
75
1 country
1
Study Start
January 29, 2024
Actual (reported)Primary Completion
September 1, 2024
Actual (reported)Study Completion
September 1, 2024
Actual (reported)The goal of this single center prospective cross-sectional study is to identify the facilitators and barriers in the course of the disease that starts when symptoms first arise until patients with solid and hematologic malignancies arrive in the emergency department (ED). The main question it aims to answer are: Is there a potential relation between the lag-time and the ED length of stay (LOS) and the chance of admission. Participants will be asked to participate in a one-time interview, that focusses on the pre-admission process.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 1, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 18, 2023
Actual (reported)August 3, 2023
Actual (reported)January 29, 2024
Actual (reported)September 1, 2024
Actual (reported)September 1, 2024
Actual (reported)Clusters of facilitators experienced by cancer patients.
Different (sub)clusters of facilitators experienced by cancer patients visiting the emergency department (ED)
Through study completion, an average of 6 months
clusters of barriers experienced by cancer patients.
Different (sub)clusters of barriers experienced by cancer patients visiting the ED
Through study completion, an average of 6 months
Time-to-speak
Through study completion, an average of 6 months
Time-to-contact
Through study completion, an average of 6 months
Time-to-present
Through study completion, an average of 6 months
Difference in group average lag-time between day, evening and night
Through study completion, an average of 6 months
Difference in group average lag-time between weekdays (Monday 08:00 till Friday 23:59) and weekend (Saturday 00:00 and Monday 7:59)
Through study completion, an average of 6 months
All adult patients with solid or hematological malignancies and receiving systemic therapy or having received systemic therapy within the last 3 months admitted to the emergency department of the Erasmus Medical Center for the oncology, hematology, lung- and neuro-oncology medical unit are eligible for inclusion.
The interview focuses on several parts of the (pre-)admission process: The first part is regarding the barriers and facilitators encountered during the (pre-)admission process. The second part will focus on the timeline that led to an emergency department (ED) visit. It will be established when and which symptoms were first detected. The third part is regarding the number and type of health care workers that were contacted before visiting the ED. The fourth part will be about the actions and considerations taken before the ED visit.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
In the emergency department (ED) of Erasmus medical center (MC) yearly around 1600 patients with cancer are presented to the ED. Based on the study design we will conduct interviews with 75 to 100 patients with solid and hematologic malignancies, who are receiving systemic therapy or have received systemic therapy within the last 3 months and are admitted to the ED department of the Erasmus MC for the oncology, hematology, lung- and neuro-oncology medical unit. If present, the interview will also be held with the family caregiver.
Erasmus MC
Rotterdam, South Holland, 3015GD, Netherlands
Jason den Duijn
Erasmus Medical Center
75 participants (actual enrollment reported by the registry).
First Submitted
July 18, 2023
First Posted
August 3, 2023
Study Start
January 29, 2024
Actual (reported)Palliative Care Yields Cancer Wellbeing Support
Eating Experience at the Comprehensive Cancer Center Wards - a Qualitative Study
Contact the study team to confirm eligibility.
Primary Completion
September 1, 2024
Actual (reported)Study Completion
September 1, 2024
Actual (reported)Last Updated
October 15, 2024
Record last verified: 2024-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: